| Year |
Citation |
Score |
| 2014 |
Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, et al. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 86: 228-40. PMID 25107591 DOI: 10.1016/J.Neuropharm.2014.07.016 |
0.56 |
|
| 2014 |
Xu J, Xu M, Bolan E, Gilbert AK, Pasternak GW, Pan YX. Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P. Synapse (New York, N.Y.). 68: 144-52. PMID 24375714 DOI: 10.1002/Syn.21727 |
0.726 |
|
| 2007 |
Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, Jaligam V, Oz M, Jayanthi LD, Samuvel DJ, Ramamoorthy S, Shippenberg TS. Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. The Journal of Biological Chemistry. 282: 35842-54. PMID 17923483 DOI: 10.1074/Jbc.M611758200 |
0.559 |
|
| 2007 |
Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Molecular Pharmacology. 71: 1222-32. PMID 17267664 DOI: 10.1124/Mol.106.027763 |
0.523 |
|
| 2005 |
Pan YX, Xu J, Bolan E, Moskowitz HS, Xu M, Pasternak GW. Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Molecular Pharmacology. 68: 866-75. PMID 15939800 DOI: 10.1124/Mol.105.011858 |
0.73 |
|
| 2005 |
Chefer VI, Czyzyk T, Bolan EA, Moron J, Pintar JE, Shippenberg TS. Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5029-37. PMID 15901784 DOI: 10.1523/Jneurosci.0854-05.2005 |
0.525 |
|
| 2004 |
Bolan EA, Pan YX, Pasternak GW. Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm. Synapse (New York, N.Y.). 51: 11-8. PMID 14579421 DOI: 10.1002/Syn.10277 |
0.733 |
|
| 2003 |
Neilan CL, Janvey AJ, Bolan E, Berezowska I, Nguyen TM, Schiller PW, Pasternak GW. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide. The Journal of Pharmacology and Experimental Therapeutics. 306: 430-6. PMID 12663687 DOI: 10.1124/Jpet.103.049742 |
0.658 |
|
| 2002 |
Bolan EA, Tallarida RJ, Pasternak GW. Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 303: 557-62. PMID 12388636 DOI: 10.1124/Jpet.102.035881 |
0.626 |
|
| 2002 |
Pan YX, Bolan E, Pasternak GW. Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype. Biochemical and Biophysical Research Communications. 297: 659-63. PMID 12270145 DOI: 10.1016/S0006-291X(02)02258-1 |
0.742 |
|
| 2002 |
Pan Y, Bolan E, Pasternak GW. Erratum to “Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype” [Biochem. Biophys. Res. Commun. 297 (2002) 659–663] Biochemical and Biophysical Research Communications. 298: 456. DOI: 10.1016/S0006-291X(02)02479-8 |
0.653 |
|
| 2001 |
Pan YX, Xu J, Mahurter L, Bolan E, Xu M, Pasternak GW. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proceedings of the National Academy of Sciences of the United States of America. 98: 14084-9. PMID 11717463 DOI: 10.1073/Pnas.241296098 |
0.585 |
|
| 2000 |
Pan YX, Xu J, Bolan E, Chang A, Mahurter L, Rossi G, Pasternak GW. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F Febs Letters. 466: 337-340. PMID 10682855 DOI: 10.1016/S0014-5793(00)01095-4 |
0.676 |
|
| 1999 |
Zuckerman A, Bolan E, De Paulis T, Schmidt D, Spector S, Pasternak GW. Pharmacological characterization of morphine-6-sulfate and codeine-6- sulfate Brain Research. 842: 1-5. PMID 10526089 DOI: 10.1016/S0006-8993(99)01766-7 |
0.543 |
|
| 1999 |
Pan YX, Xu J, Bolan E, Abbadie C, Chang A, Zuckerman A, Rossi G, Pasternak GW. Identification and characterization of three new alternatively spliced μ-opioid receptor isoforms Molecular Pharmacology. 56: 396-403. PMID 10419560 DOI: 10.1124/Mol.56.2.396 |
0.693 |
|
| 1999 |
Schuller AG, King MA, Zhang J, Bolan E, Pan YX, Morgan DJ, Chang A, Czick ME, Unterwald EM, Pasternak GW, Pintar JE. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nature Neuroscience. 2: 151-6. PMID 10195199 DOI: 10.1038/5706 |
0.648 |
|
| 1998 |
Goldberg IE, Rossi GC, Letchworth SR, Mathis JP, Ryan-Moro J, Leventhal L, Su W, Emmel D, Bolan EA, Pasternak GW. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. The Journal of Pharmacology and Experimental Therapeutics. 286: 1007-13. PMID 9694962 |
0.685 |
|
| 1997 |
Rossi GC, Leventhal L, Bolan E, Pasternak GW. Pharmacological characterization of orphanin FQ/nociceptin and its fragments Journal of Pharmacology and Experimental Therapeutics. 282: 858-865. PMID 9262352 |
0.642 |
|
| Show low-probability matches. |